KMT2A and acute myeloid leukemia: In contrast, AMG-47a provided little protection against the same necroptotic stimulus in MLL-AF9, MLL-AF9-NRas and MLL-ENL AML cells (Fig. 1E, Supplementary Fig. 1C–E).